about
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED);...
Read More
23.04
-0.11
(-0.48%)
271.5K
XNAS Volume
XNAS 13 Jan, 2026 4:30 PM (EST)
Board Meeting
The board meeting for Oculis Holding AG is scheduled for today, for the purpose of 44th Annual J.P. Morgan Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Oculis Holding AG Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..